A light is coming soon from the tunnel
Dear , Colleague !
In WORLD POLSE
Canadian researchers have announced that initial results from human
clinical trials of an HIV vaccine showed no adverse effects. The vaccine,
which was developed by researchers at the University of Western Ontario, is
the first preventative vaccine using a genetically modified killed whole
virus. The vaccine - called SAV001-H - was approved by the US Food and Drug
Administration in 2011 to begin human clinical trials and is the only HIV
vaccine currently being developed in Canada...
To test the safety and tolerability of the virus, 24 healthy men and women
with HIV were randomly divided into two treatment groups, one receiving the
vaccine and one receiving a placebo. The participants, aged 18 to 50 years,
were given monthly checkups and so far have shown no local reactions or
symptoms... After receiving the vaccine, the experimental group showed
increased levels of HIV-1 antibodies which means that the vaccine was
working to stimulate immune responses.
The second phase of clinical trials will begin in 2013, when the
researchers will test the vaccine on about 600 HIV-negative volunteers at
high risk for HIV infection. This test will be conducted by the CIHR
Canadian HIV Trials Network. Phase 3 will enroll about 6,000 HIV negative
volunteers at high risk for the disease. The first test was carried out in
the United States on persons selected at two Los Angeles hospitals. The
second and third phases will be conducted in Canada, the United States, and
various European countries.
Surely, a light is coming soon from the tunnel.